Dashboard
Manage Tickers

CLSNImunon, Inc.

Nasdaq imunon.com


nm (nm)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 468.28 $ 9.96 (2.17 %)
DIA $ 409.73 $ 1.01 (0.25 %)
SPY $ 554.79 $ 5.63 (1.03 %)
TLT $ 100.61 $ -0.08 (-0.08 %)
GLD $ 232.25 $ -0.37 (-0.16 %)
$ na
-- x --
-- x --
-- - --
nm - nm
0
na
15.91M
nm
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-13-2024 03-31-2024 10-Q
3 03-28-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-30-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-31-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-14-2021 03-31-2021 10-Q
15 03-19-2021 12-31-2020 10-K
16 11-16-2020 09-30-2020 10-Q
17 08-14-2020 06-30-2020 10-Q
18 05-15-2020 03-31-2020 10-Q
19 03-25-2020 12-31-2019 10-K
20 11-14-2019 09-30-2019 10-Q
21 08-14-2019 06-30-2019 10-Q
22 05-15-2019 03-31-2019 10-Q
23 03-29-2019 12-31-2018 10-K
24 11-14-2018 09-30-2018 10-Q
25 08-14-2018 06-30-2018 10-Q
26 05-11-2018 03-31-2018 10-Q
27 03-27-2018 12-31-2017 10-K
28 11-14-2017 09-30-2017 10-Q
29 08-14-2017 06-30-2017 10-Q
30 05-12-2017 03-31-2017 10-Q
31 03-24-2017 12-31-2016 10-K
32 11-10-2016 09-30-2016 10-Q
33 08-15-2016 06-30-2016 10-Q
34 05-16-2016 03-31-2016 10-Q
35 03-30-2016 12-31-2015 10-K
36 11-05-2015 09-30-2015 10-Q
37 08-10-2015 06-30-2015 10-Q
38 05-11-2015 03-31-2015 10-Q
39 03-12-2015 12-31-2014 10-K
40 11-10-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

celsion-corporation-announces-company-name-change-to-imunon-to-trade-under-symbol-imnn-effective-as-of-sept-21
Celsion Corporation Announces Company Name...
09/19/2022 20:32:11

Celsion Corporation (NASDAQ:CLSN), a clinical-stage drug development company, today announced a company name change to Imunon, ...

important-biotech-catalysts-for-september-15-2022---end-of-the-day-summary
Important Biotech Catalysts For September ...
09/15/2022 22:47:02

celsion-completes-enrollment-of-the-phase-iii-ovation-2-study-with-gen-1-in-advanced-ovarian-cancer
Celsion Completes Enrollment Of The Phase ...
09/15/2022 12:36:35

110 Patients Enrolled in Study Comparing Novel Gene-Mediated Immunotherapy plus Neoadjuvant Chemotherapy versus Neoadjuvant Che...

celsion-earnings-perspective-return-on-capital-employed
Celsion Earnings Perspective: Return On Ca...
09/09/2022 14:17:30

According to Benzinga Pro data, during Q2, Celsion (NASDAQ:CLSN) posted sales of $125 thousand. Earnings were up 42.31%, but Ce...

celsion-says-placcine-dna-based-vaccine-demonstrated-robust-response-in-murine-model
Celsion Says PLACCINE DNA-Based Vaccine De...
09/01/2022 12:33:39

PLACCINE DNA-based Vaccine Demonstrates Robust Response in Murine Model LAWRENCEVILLE, N.J., Sept. 01, 2022 (GLOBE NEWSWIRE) -...

celsion-q2-eps-087-beats-112-estimate-sales-12500k-beat-8000k-estimate
Celsion Q2 EPS $(0.87) Beats $(1.12) Estim...
08/15/2022 12:17:03

Celsion (NASDAQ:CLSN) reported quarterly losses of $(0.87) per share which beat the analyst consensus estimate of $(1.12) by 22...

recap-celsion-q2-earnings
Recap: Celsion Q2 Earnings
08/15/2022 12:16:39

  Celsion (NASDAQ:CLSN) reported its Q2 earnings results on Monday, August 15, 2022 at 08:00 AM. Here's what investors ne...

earnings-scheduled-for-august-15-2022
Earnings Scheduled For August 15, 2022
08/15/2022 08:30:10

  Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.

earnings-outlook-for-celsion
Earnings Outlook For Celsion
08/12/2022 14:10:10

  Celsion (NASDAQ:CLSN) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors n...

celsion-appoints-dr-corinne-le-goff-as-president-and-chief-executive-officer
Celsion Appoints Dr. Corinne Le Goff As Pr...
07/19/2022 12:32:07

recap-of-tuesdays-biotech-catalysts---end-of-the-day-summary
Recap of Tuesday's Biotech Catalysts - End...
06/21/2022 21:38:14

Ionis (NASDAQ: IONS) announced that Eplontersen met co-primary and secondary endpoints in interim analysis of the Phase 3 NEURO...

celsion-reports-data-safety-monitoring-board-unanimous-recommendation-to-continue-dosing-patients-in-the-phase-ii-portion-of-the-ovation-2-study-with-gen-1-in-advanced-ovarian-cancer
Celsion Reports Data Safety Monitoring Boa...
06/21/2022 12:40:15

Novel Gene-Mediated Immunotherapy is Safe and Demonstrates an Acceptable Risk/Benefit Full Enrollment Expected by Third Quarte...

clsn-ovation-2-study-85-enrolled
CLSN: OVATION 2 Study 85% Enrolled…
06/18/2022 11:00:46

By David Bautz, PhD NASDAQ:CLSN READ THE FULL CLSN RESEARCH REPORT

celsion-q1-earnings-insights
Celsion: Q1 Earnings Insights
05/16/2022 12:16:12

  Celsion (NASDAQ:CLSN) reported its Q1 earnings results on Monday, May 16, 2022 at 08:00 AM. Here's what investors need ...

celsion-q1-eps-182-misses-099-estimate-sales-12500k-beat-10000k-estimate
Celsion Q1 EPS $(1.82) Misses $(0.99) Esti...
05/16/2022 12:14:59

Celsion (NASDAQ:CLSN) reported quarterly losses of $(1.82) per share which missed the analyst consensus estimate of $(0.99) by ...

earnings-scheduled-for-may-16-2022
Earnings Scheduled For May 16, 2022
05/16/2022 09:18:44

  Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 p...

earnings-outlook-for-celsion
Earnings Outlook For Celsion
05/13/2022 14:03:42

Celsion (NASDAQ:CLSN) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
04/21/2022 21:31:50

Gainers

celsions-formulated-dna-plasmid-covid-19-vaccine-candidate-shows-activity-against-two-strains
Celsion's Formulated DNA Plasmid COVID-19 ...
04/21/2022 19:24:44

celsion-corporation-highlighted-placcine-vaccine-platform-technology-during-oral-presentation-at-world-vaccine-congress
Celsion Corporation Highlighted PLACCINE V...
04/21/2022 15:32:03

Celsion Corporation Highlighted its PLACCINE Vaccine Platform Technology During Oral Presentation at the World Vaccine Congress...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION